slotkoers
Shanghai S.E.
00:00:00 26-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
15,6
CNY
|
+3,24%
|
|
+5,62%
|
-35,56%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
11.231
|
28.827
|
46.842
|
35.397
|
21.777
|
14.032
|
-
|
-
|
Bedrijfswaarde
1 |
11.231
|
28.827
|
46.842
|
35.397
|
21.777
|
14.032
|
14.032
|
14.032
|
K/w-verhouding
|
46,5
x
|
76,2
x
|
74
x
|
38,2
x
|
20,9
x
|
11,2
x
|
8,84
x
|
9,02
x
|
Dividendrendement
|
-
|
-
|
0,44%
|
0,94%
|
2,07%
|
3,11%
|
3,62%
|
4,36%
|
Marktkapitalisatie/omzet
|
5,57
x
|
10,9
x
|
11,5
x
|
6,5
x
|
3,94
x
|
2,23
x
|
1,94
x
|
1,76
x
|
Bedrijfswaarde/omzet
|
5,57
x
|
10,9
x
|
11,5
x
|
6,5
x
|
3,94
x
|
2,23
x
|
1,94
x
|
1,76
x
|
Bedrijfswaarde/EBITDA
|
23,6
x
|
40,7
x
|
44,8
x
|
24,4
x
|
14
x
|
7,85
x
|
6,61
x
|
5,89
x
|
Bedrijfswaarde/FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
3,93
x
|
9,35
x
|
10,2
x
|
6,68
x
|
2,57
x
|
1,51
x
|
1,36
x
|
1,22
x
|
Aantal aandelen (in duizenden)
|
805.662
|
805.235
|
832.596
|
834.255
|
899.486
|
899.486
|
-
|
-
|
Referentieprijs
2 |
13,94
|
35,80
|
56,26
|
42,43
|
24,21
|
15,60
|
15,60
|
15,60
|
Datum van publicatie
|
8/04/20
|
27/04/21
|
19/04/22
|
27/04/23
|
8/04/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
2.017
|
2.647
|
4.063
|
5.445
|
5.523
|
6.294
|
7.251
|
7.954
|
EBITDA
1 |
476,4
|
708,9
|
1.045
|
1.452
|
1.554
|
1.787
|
2.122
|
2.381
|
Bedrijfsresultaat (EBIT)
1 |
285,4
|
456,1
|
753,6
|
1.108
|
1.176
|
1.391
|
1.647
|
1.817
|
Operationele Marge
|
14,15%
|
17,23%
|
18,55%
|
20,35%
|
21,29%
|
22,1%
|
22,72%
|
22,84%
|
Resultaat voor belastingen (EBT)
1 |
286,9
|
449,9
|
744,7
|
1.104
|
1.181
|
1.390
|
1.646
|
1.816
|
Nettowinst (verlies)
1 |
237,8
|
380,6
|
633,9
|
920,9
|
1.033
|
1.259
|
1.589
|
1.556
|
Nettomarge
|
11,79%
|
14,38%
|
15,6%
|
16,91%
|
18,71%
|
20%
|
21,91%
|
19,56%
|
WPA
2 |
0,3000
|
0,4700
|
0,7600
|
1,110
|
1,160
|
1,398
|
1,764
|
1,730
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF-marge
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
2 |
-
|
-
|
0,2500
|
0,4000
|
0,5000
|
0,4850
|
0,5650
|
0,6800
|
Datum van publicatie
|
8/04/20
|
27/04/21
|
19/04/22
|
27/04/23
|
8/04/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (netto-inkomsten/eigen vermogen)
|
8,52%
|
12,9%
|
15,1%
|
18,7%
|
13,1%
|
14,4%
|
15,3%
|
13,6%
|
ROA (netto-inkomsten/totale activa)
|
-
|
-
|
10,5%
|
12,3%
|
-
|
9,79%
|
10,5%
|
10,5%
|
Totale activa
1 |
-
|
-
|
6.021
|
7.477
|
-
|
12.864
|
15.199
|
14.866
|
Nettoactief per aandeel
2 |
3,540
|
3,830
|
5,500
|
6,350
|
9,410
|
10,40
|
11,50
|
12,80
|
Cashflow per aandeel
2 |
0,6900
|
0,5000
|
0,8100
|
1,470
|
1,510
|
1,730
|
1,980
|
2,280
|
Capex
1 |
313
|
316
|
572
|
705
|
925
|
739
|
633
|
1.241
|
Capex/omzet
|
15,53%
|
11,93%
|
14,07%
|
12,95%
|
16,75%
|
11,74%
|
8,73%
|
15,61%
|
Datum van publicatie
|
8/04/20
|
27/04/21
|
19/04/22
|
27/04/23
|
8/04/24
|
-
|
-
|
-
|
Laatste slotkoers
15,6
CNY Gemiddelde koersdoel
23,2
CNY Spread / Gemiddelde doel +48,73% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| -35,56% | 1,94 mld. | | +25,83% | 661 mld. | | +27,00% | 566 mld. | | -6,76% | 352 mld. | | +20,34% | 332 mld. | | +3,00% | 283 mld. | | +13,09% | 231 mld. | | +5,46% | 200 mld. | | -9,61% | 195 mld. | | -6,26% | 145 mld. |
Farmaceutische producten - Andere
|